Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: Synthesis and biological evaluation

Sung Hwa Yoon, Jiaxiang Wu, Whei Mei Wu, Laszlo Prokai, Nicholas Bodor

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A chemical targeting system for [Leu2, Pip3]-TRH (Gln,Leu,Pip) was synthesized in order to allow its specific delivery to the central nervous system (CNS). Sequential metabolism of the obtained 'packaged' chemical delivery system, (CDS), DHT-Pro-Pro-Gln-Leu-Pip-OCh, should yield a 'locked- in' precursor following the oxidative conversion of the dihydrotrigonellyl (DHT) to the trigonellyl (T+) moiety, followed by removal of the cholesteryl function and cleavage of the T+-Pro-Pro by prolyl endopeptidase. The antagonism of barbiturate-induced sleeping time was used to assess the activity of the CDS. The sleeping time after administration of vehicle and [Leu2]-TRH was 100.5 ± 6.3 min, and 78.2 ± 4.7 min, respectively. The [Leu2, Pip3]-TRH-CDS showed a significant decrease in sleeping time (58.2 ± 3.4 min) compared to the vehicle or [Leu2]-TRH. These results indicate successful brain delivery of the precursor construct, and an effective release of the active GlnLeuPip in the brain. (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)1059-1063
Number of pages5
JournalBioorganic and Medicinal Chemistry
Volume8
Issue number5
DOIs
StatePublished - 1 May 2000

Fingerprint

prolyl oligopeptidase
Brain
Neurology
Metabolism
Central Nervous System
barbituric acid

Cite this

Yoon, Sung Hwa ; Wu, Jiaxiang ; Wu, Whei Mei ; Prokai, Laszlo ; Bodor, Nicholas. / Brain-targeted chemical delivery of [Leu2, Pip3]-TRH : Synthesis and biological evaluation. In: Bioorganic and Medicinal Chemistry. 2000 ; Vol. 8, No. 5. pp. 1059-1063.
@article{798d1e66533346f9be91dd12250d491c,
title = "Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: Synthesis and biological evaluation",
abstract = "A chemical targeting system for [Leu2, Pip3]-TRH (Gln,Leu,Pip) was synthesized in order to allow its specific delivery to the central nervous system (CNS). Sequential metabolism of the obtained 'packaged' chemical delivery system, (CDS), DHT-Pro-Pro-Gln-Leu-Pip-OCh, should yield a 'locked- in' precursor following the oxidative conversion of the dihydrotrigonellyl (DHT) to the trigonellyl (T+) moiety, followed by removal of the cholesteryl function and cleavage of the T+-Pro-Pro by prolyl endopeptidase. The antagonism of barbiturate-induced sleeping time was used to assess the activity of the CDS. The sleeping time after administration of vehicle and [Leu2]-TRH was 100.5 ± 6.3 min, and 78.2 ± 4.7 min, respectively. The [Leu2, Pip3]-TRH-CDS showed a significant decrease in sleeping time (58.2 ± 3.4 min) compared to the vehicle or [Leu2]-TRH. These results indicate successful brain delivery of the precursor construct, and an effective release of the active GlnLeuPip in the brain. (C) 2000 Elsevier Science Ltd.",
author = "Yoon, {Sung Hwa} and Jiaxiang Wu and Wu, {Whei Mei} and Laszlo Prokai and Nicholas Bodor",
year = "2000",
month = "5",
day = "1",
doi = "10.1016/S0968-0896(00)00043-2",
language = "English",
volume = "8",
pages = "1059--1063",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Ltd",
number = "5",

}

Brain-targeted chemical delivery of [Leu2, Pip3]-TRH : Synthesis and biological evaluation. / Yoon, Sung Hwa; Wu, Jiaxiang; Wu, Whei Mei; Prokai, Laszlo; Bodor, Nicholas.

In: Bioorganic and Medicinal Chemistry, Vol. 8, No. 5, 01.05.2000, p. 1059-1063.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Brain-targeted chemical delivery of [Leu2, Pip3]-TRH

T2 - Synthesis and biological evaluation

AU - Yoon, Sung Hwa

AU - Wu, Jiaxiang

AU - Wu, Whei Mei

AU - Prokai, Laszlo

AU - Bodor, Nicholas

PY - 2000/5/1

Y1 - 2000/5/1

N2 - A chemical targeting system for [Leu2, Pip3]-TRH (Gln,Leu,Pip) was synthesized in order to allow its specific delivery to the central nervous system (CNS). Sequential metabolism of the obtained 'packaged' chemical delivery system, (CDS), DHT-Pro-Pro-Gln-Leu-Pip-OCh, should yield a 'locked- in' precursor following the oxidative conversion of the dihydrotrigonellyl (DHT) to the trigonellyl (T+) moiety, followed by removal of the cholesteryl function and cleavage of the T+-Pro-Pro by prolyl endopeptidase. The antagonism of barbiturate-induced sleeping time was used to assess the activity of the CDS. The sleeping time after administration of vehicle and [Leu2]-TRH was 100.5 ± 6.3 min, and 78.2 ± 4.7 min, respectively. The [Leu2, Pip3]-TRH-CDS showed a significant decrease in sleeping time (58.2 ± 3.4 min) compared to the vehicle or [Leu2]-TRH. These results indicate successful brain delivery of the precursor construct, and an effective release of the active GlnLeuPip in the brain. (C) 2000 Elsevier Science Ltd.

AB - A chemical targeting system for [Leu2, Pip3]-TRH (Gln,Leu,Pip) was synthesized in order to allow its specific delivery to the central nervous system (CNS). Sequential metabolism of the obtained 'packaged' chemical delivery system, (CDS), DHT-Pro-Pro-Gln-Leu-Pip-OCh, should yield a 'locked- in' precursor following the oxidative conversion of the dihydrotrigonellyl (DHT) to the trigonellyl (T+) moiety, followed by removal of the cholesteryl function and cleavage of the T+-Pro-Pro by prolyl endopeptidase. The antagonism of barbiturate-induced sleeping time was used to assess the activity of the CDS. The sleeping time after administration of vehicle and [Leu2]-TRH was 100.5 ± 6.3 min, and 78.2 ± 4.7 min, respectively. The [Leu2, Pip3]-TRH-CDS showed a significant decrease in sleeping time (58.2 ± 3.4 min) compared to the vehicle or [Leu2]-TRH. These results indicate successful brain delivery of the precursor construct, and an effective release of the active GlnLeuPip in the brain. (C) 2000 Elsevier Science Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0034076459&partnerID=8YFLogxK

U2 - 10.1016/S0968-0896(00)00043-2

DO - 10.1016/S0968-0896(00)00043-2

M3 - Article

C2 - 10882017

AN - SCOPUS:0034076459

VL - 8

SP - 1059

EP - 1063

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 5

ER -